Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa

被引:73
|
作者
de Chial, M
Ghysels, B
Beatson, SA
Geoffroy, V
Meyer, JM
Pattery, T
Baysse, C
Chablain, P
Parsons, YN
Winstanley, C
Cordwell, SJ
Cornelis, P
机构
[1] Free Univ Brussels VIB, Lab Microbial Interact, B-1050 Brussels, Belgium
[2] Univ Oxford, MRC, Funct Genet Unit, Dept Human Anat & Genet, Oxford OX1 3QX, England
[3] Univ Strasbourg, Lab Microbiol & Genet, UPRES A 7010, F-67000 Strasbourg, France
[4] Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England
[5] Australian Proteome Anal Facil, Sydney, NSW 2109, Australia
来源
MICROBIOLOGY-SGM | 2003年 / 149卷
关键词
D O I
10.1099/mic.0.26136-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa produces, under conditions of iron limitation, a high-affinity siderophore, pyoverdine (PVD), which is recognized at the level of the outer membrane by a specific TonB-dependent receptor, FpvA. So far, for P. aeruginosa, three different PVDs, differing in their peptide chain, have been described (types I-III), but only the FpvA receptor for type I is known. Two PVD-producing P. aeruginosa strains, one type II and one type III, were mutagenized by a mini-TnphoA3 transposon. In each case, one mutant unable to grow in the presence of the strong iron chelator ethylenediaminedihydroxyphenylacetic acid (EDDHA) and the cognate PVD was selected. The first mutant, which had an insertion in the pvdE gene, upstream of fpvA, was unable to take up type II PVD and showed resistance to pyocin S3, which is known to use type II FpvA as receptor. The second mutant was unable to take up type III PVD and had the transposon insertion in fpvA. Cosmid libraries of the respective type II and type III PVD wild-type strains were constructed and screened for clones restoring the capacity to grow in the presence of PVD. From the respective complementing genomic fragments, type II and type III fpvA sequences were determined. When in trans, type II and type III fpvA restored PVD production, uptake, growth in the presence of EDDHA and, in the case of type II fpvA, pyocin S3 sensitivity. Complementation of fpvA mutants obtained by allelic exchange was achieved by the presence of cognate fpvA in trans. All three receptors posses an N-terminal extension of about 70 amino acids, similar to FecA of Escherichia coli, but only FpvAI has a TAT export sequence at its N-terminal end.
引用
收藏
页码:821 / 831
页数:11
相关论文
共 50 条
  • [31] Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentration
    Singh, G.
    Wu, B.
    Baek, M. S.
    Camargo, A.
    Nguyen, A.
    Slusher, N. A.
    Srinivasan, R.
    Wiener-Kronish, J. P.
    Lynch, S. V.
    MICROBIAL PATHOGENESIS, 2010, 49 (04) : 196 - 203
  • [32] Cell-type-specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system
    Armentrout, Erin, I
    Kundracik, Emma C.
    Rietsch, Arne
    MOLECULAR MICROBIOLOGY, 2021, 115 (02) : 305 - 319
  • [33] Synergistic pore formation by type III toxin translocators of Pseudomonas aeruginosa
    Faudry, Eric
    Vernier, Gregory
    Neumann, Emmanuelle
    Forge, Vincent
    Attree, Ina
    BIOCHEMISTRY, 2006, 45 (26) : 8117 - 8123
  • [34] Oligoribonuclease is required for the type III secretion system and pathogenesis of Pseudomonas aeruginosa
    Chen, Gukui
    Zhao, Qiang
    Zhu, Feng
    Chen, Ronghao
    Jin, Yongxin
    Liu, Chang
    Pan, Xiaolei
    Jin, Shouguang
    Wu, Weihui
    Cheng, Zhihui
    MICROBIOLOGICAL RESEARCH, 2016, 188 : 90 - 96
  • [35] ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
    Yahr, TL
    Vallis, AJ
    Hancock, MK
    Barbieri, JT
    Frank, DW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13899 - 13904
  • [36] Metabolic regulation of type III secretion gene expression in Pseudomonas aeruginosa
    Rietsch, A
    Mekalanos, JJ
    MOLECULAR MICROBIOLOGY, 2006, 59 (03) : 807 - 820
  • [37] Alveolar response to Pseudomonas aeruginosa:: Role of the type III secretion system
    Ader, F
    Le Berre, R
    Faure, K
    Gosset, P
    Epaulard, O
    Toussaint, B
    Polack, B
    Nowak, E
    Viget, NB
    Kipnis, E
    Guery, BP
    INFECTION AND IMMUNITY, 2005, 73 (07) : 4263 - 4271
  • [38] The type III toxins of Pseudomonas aeruginosa disrupt epithelial barrier function
    Soong, Grace
    Parker, Dane
    Magargee, Mariah
    Prince, Alice S.
    JOURNAL OF BACTERIOLOGY, 2008, 190 (08) : 2814 - 2821
  • [39] Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU
    Tamura, M
    Ajayi, T
    Allmond, LR
    Moriyama, K
    Wiener-Kronish, JP
    Sawa, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (02) : 323 - 331
  • [40] Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU
    Sato, H
    Feix, JB
    Hillard, CJ
    Frank, DW
    JOURNAL OF BACTERIOLOGY, 2005, 187 (03) : 1192 - 1195